CTMX Stock Price | CytomX Therapeutics Inc. Stock Quote (U.S.: Nasdaq)

0
22


CytomX Therapeutics Inc.

CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.



Source : MTV